Perry Andrew
G1 Therapeutics, Inc. · Chief Commercial Officer
Perry Andrew is listed in filings as Chief Commercial Officer at G1 Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 18, 2024, including sale activity. Recent filings connect the profile to G1 Therapeutics, Inc. (GTHX). The current snapshot covers public activity from Jul 3, 2024 to Sep 18, 2024. Reported amounts are shown as $818.5K to $183.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $3.4k1.3k shares | SellJul 5, 2024 | $2.51 | $7.16 |